Latest News

Date Title Topic
23 Nov 2016 FDA Approves Daratumumab in Combination with Lenalidomide and Dexamethasone or Bortezomib and Dexamethasone for Multiple Myeloma Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
23 Nov 2016 Media Alert: Catch Up on Cancer News at ESMO Asia 2016
21 Nov 2016 EMA Revises the Guideline on First-in-Human Clinical Trials Bioethics, legal and economic issues
Travel Grants
16 Nov 2016 Direct Small-Molecule Inhibitors of KRAS Translational research
15 Nov 2016 EMA Recommends Extension of Therapeutic Indications for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
14 Nov 2016 EMA Recommends Extension of Therapeutic Indications for Vandetanib Endocrine cancers - Anticancer agents & Biologic therapy
11 Nov 2016 FDA Approves Nivolumab for SCCHN Head and neck cancers - Cancer Immunology and Immunotherapy
09 Nov 2016 Pembrolizumab in Head & Neck Cancer Head and neck cancers
08 Nov 2016 How Big Data Can Be Used for the Development and Regulation of Medicines Translational research
08 Nov 2016 Media Alert: ESMO Asia 2016 – Cancer Experts Meet in Singapore from 16 to 19 December 2016
Webcasts
07 Nov 2016 Personalised Cancer Vaccines Cancer Immunology and Immunotherapy
04 Nov 2016 KEYNOTE-045 Study Meets Primary Endpoint and Stops Early Genitourinary cancers - Cancer Immunology and Immunotherapy
03 Nov 2016 Now Available in Russian, the ESMO/ACF Patient Guide on Pancreatic Cancer